Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
PerfusionTech is a Copenhagen-based MedTech company founded in 2016. It develops and sells image analysis software for intraoperative perfusion quantification and visualization. Its core product, PerfusionWorks, is designed for video-assisted surgical workflows. By analyzing ICG fluorescence videos captured by existing surgical imaging systems, it helps surgeons assess tissue perfusion in real time and reduce clinical risks caused by bleeding or misjudgments of blood supply.
A typical PerfusionWorks workflow is as follows: the physician selects a region of interest on a touchscreen, injects the ICG fluorescent dye, and the system begins measurement, delivering quantitative perfusion results within minutes. The product emphasizes real-time performance, quantification, and ease of use. It supports robotic, laparoscopic, and open surgery, and can be used across multiple specialties, including colorectal surgery, general surgery, orthopedics, and plastic surgery. The website also states that it is compatible with existing surgical imaging systems and has been tested with related systems from Intuitive Surgical, Olympus, Karl Storz, Diagnostic Green, and others.
Publicly available information does not provide specific plans, pricing, contract models, or procurement processes. The phrase “register to get the first month free” appears multiple times. The company states that PerfusionWorks is already sold in Europe and has customer installation records, but it does not clearly disclose details about non-European markets, hospital procurement cycles, after-sales service, or training models.
The product has obtained CE marking, with its CE scope expanded from colorectal cancer surgery to a broader range of surgical specialties. The company received ISO 13485 certification in 2023 and submitted a CE marking application under the MDR in 2024. Its patent portfolio covers areas such as perfusion assessment, automated perfusion measurement, vessel identification in fluorescence imaging, abnormal perfusion patterns, and lymph node mapping, giving it a certain degree of technical defensibility.
Its strengths include a clearly defined clinical problem, compatibility with existing surgical imaging systems, the ability to turn subjective fluorescence interpretation into quantitative metrics, and support from research and certifications. Its weaknesses are that public materials lack common SaaS-related information, such as deployment methods, permission management, APIs, data security, pricing, and service levels. Some pages also contain templated copy, which reduces the completeness of the available information.
It is better suited for European hospitals, surgical centers, and colorectal or other video-assisted surgical teams evaluating adoption. The main content does not provide information on access from China, so actual testing is required. In addition, deploying this type of medical software in China would require attention to local registration, regulatory compliance, and compatibility with hospital equipment.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on perfusiontech.com official site.
perfusiontech.com is an Unknown Health provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach perfusiontech.com directly.